CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2012.
Third Quarter 2012 Highlights
Completed acquisition of Cardiocore Lab, Inc., a leading research services business
Introduced CardioNet’s new wireless event device, wEvent
Generated positive adjusted EBITDA of $0.3 million in the third quarter 2012
Experienced increased patient volume year over year
